Progesterone Market Trends

• Hormonal imbalances, such as polycystic ovary syndrome (PCOS), endometriosis, and irregular menstrual cycles, are becoming more prevalent globally. For instance, as per the WHO, polycystic ovary syndrome (PCOS) affects an estimated 8% to 13% of reproductive-aged women. Similarly, as per the CDC, PCOS is one of the most common causes of female infertility, affecting 6% to 12% (as many as 5 million) of U.S. women of reproductive age.
  
• These conditions often require progesterone therapy to manage symptoms and restore hormonal balance. Thus, increasing prevalence of hormonal disorders has emerged as a significant driver of the market.
  
• Additionally, as awareness grows and diagnoses improve, the demand for progesterone-based treatments will further continue to rise, thereby driving the market growth.
  

However, side effects and safety concerns represent a significant restraint for the market growth. These side effects range from mild symptoms such as nausea, headaches, and breast tenderness to more severe complications like blood clots and mood changes. Additionally, safety concerns regarding long-term use and potential risks, particularly in specific patient populations such as pregnant women or individuals with certain medical conditions may hamper the adoption rates, thereby hindering the industry growth.